Daniel Tassé

« BACK
Daniel Tassé – Chairman and Chief Executive Officer
“When people become critically ill, their entire world changes — they are fully reliant on healthcare professionals, drugs, and technology. They have no choice. That’s where we can make a real difference. By providing advanced therapies and support to the professionals who treat them in the most crucial moments of their lives, we can give them the solutions that no one else is offering.”

Daniel Tassé has served as our President, Chief Executive Officer, and a member of our board of directors since January 2008. Mr. Tassé was appointed Chairman in October 2009. Prior to joining us, from October 2004 to January 2008, Mr. Tassé served as General Manager of the Pharmaceuticals and Technologies Business Unit of Baxter International, Inc., a global diversified healthcare company. Baxter’s Pharmaceuticals and Technologies Business Unit includes the Anesthesia and Critical Care business, the Hospital IV Drug business, the Contract Manufacturing business, and the Formulation Technology business. From July 2001 to October 2004, Mr. Tassé served as Vice President and Regional Director for Australasia at GlaxoSmithKline, a healthcare company. Mr. Tassé holds a BS in Biochemistry from the University of Montreal. As our President and Chief Executive Officer, Mr. Tassé provides a critical contribution to our board of directors as a result of his extensive track record of business building in the healthcare industry, his strong background within critical care, his global management experience, and his detailed knowledge of the pharmaceutical industry, our company, employees, client base, and competitors.